Literature DB >> 12721371

Transgenic overexpression of galanin in the dorsal root ganglia modulates pain-related behavior.

Fiona E Holmes1, Andrea Bacon, Robert J P Pope, Penny A Vanderplank, Niall C H Kerr, Madhu Sukumaran, Vassilis Pachnis, David Wynick.   

Abstract

The neuropeptide galanin is expressed in the dorsal root ganglia (DRG) and spinal cord and is thought to be involved in the modulation of pain processing. However, its mechanisms of action are complex and poorly understood, as both facilitatory and inhibitory effects have been described. To understand further the role played by galanin in nociception, we have generated two transgenic lines that overexpress galanin in specific populations of primary afferent DRG neurons in either an inducible or constitutive manner. In the first line, a previously defined enhancer region from the galanin locus was used to target galanin to the DRG (Gal-OE). Transgene expression recapitulates the spatial endogenous galanin distribution pattern in DRG neurons and markedly overexpresses the peptide in the DRG after nerve injury but not in the uninjured state. In the second line, an enhancer region of the c-Ret gene was used to constitutively and ectopically target galanin overexpression to the DRG (Ret-OE). The expression of this second transgene does not alter significantly after nerve injury. Here, we report that intact Ret-OE, but not Gal-OE, animals have significantly elevated mechanical and thermal thresholds. After nerve damage, using a spared nerve-injury model, mechanical allodynia is attenuated markedly in both the Gal-OE and Ret-OE mice compared with WT controls. These results support an inhibitory role for galanin in the modulation of nociception both in intact animals and in neuropathic pain states.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721371      PMCID: PMC156346          DOI: 10.1073/pnas.0937087100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  58 in total

Review 1.  Galanin receptor subtypes.

Authors:  T A Branchek; K E Smith; C Gerald; M W Walker
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

Review 2.  The biological role of galanin in normal and neuropathic states.

Authors:  B J Kerr; D Wynick; S W Thompson; S B McMahon
Journal:  Prog Brain Res       Date:  2000       Impact factor: 2.453

3.  Effects of galanin on wide-dynamic range neuron activity in the spinal dorsal horn of rats with sciatic nerve ligation.

Authors:  S Xu; Y Zhang; T Lundeberg; L Yu
Journal:  Regul Pept       Date:  2000-11-24

4.  Targeted disruption of the galanin gene reduces the number of sensory neurons and their regenerative capacity.

Authors:  F E Holmes; S Mahoney; V R King; A Bacon; N C Kerr; V Pachnis; R Curtis; J V Priestley; D Wynick
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

5.  The glial cell line-derived neurotrophic factor family receptor components are differentially regulated within sensory neurons after nerve injury.

Authors:  D L Bennett; T J Boucher; M P Armanini; K T Poulsen; G J Michael; J V Priestley; H S Phillips; S B McMahon; D L Shelton
Journal:  J Neurosci       Date:  2000-01-01       Impact factor: 6.167

6.  Effects of intrathecal galanin on nociceptive responses in rats with mononeuropathy.

Authors:  L C Yu; S Lundeberg; H An; F X Wang; T Lundeberg
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

7.  The galanin receptor type 2 initiates multiple signaling pathways in small cell lung cancer cells by coupling to G(q), G(i) and G(12) proteins.

Authors:  N Wittau; R Grosse; F Kalkbrenner; A Gohla; G Schultz; T Gudermann
Journal:  Oncogene       Date:  2000-08-31       Impact factor: 9.867

8.  Spared nerve injury: an animal model of persistent peripheral neuropathic pain.

Authors:  Isabelle Decosterd; Clifford J Woolf
Journal:  Pain       Date:  2000-08       Impact factor: 6.961

9.  Excitatory effects of galanin in the spinal cord of intact, anaesthetized rats.

Authors:  A J Reeve; K Walker; L Urban; A Fox
Journal:  Neurosci Lett       Date:  2000-12-01       Impact factor: 3.046

10.  Galanin knockout mice reveal nociceptive deficits following peripheral nerve injury.

Authors:  B J Kerr; W B Cafferty; Y K Gupta; A Bacon; D Wynick; S B McMahon; S W Thompson
Journal:  Eur J Neurosci       Date:  2000-03       Impact factor: 3.386

View more
  26 in total

1.  Analgesic properties of a peripherally acting and GalR2 receptor-preferring galanin analog in inflammatory, neuropathic, and acute pain models.

Authors:  Cameron S Metcalf; Brian D Klein; Daniel R McDougle; Liuyin Zhang; Misty D Smith; Grzegorz Bulaj; H Steve White
Journal:  J Pharmacol Exp Ther       Date:  2014-10-27       Impact factor: 4.030

Review 2.  Galanin and its receptors in neurological disorders.

Authors:  Linda Lundström; Anna Elmquist; Tamas Bartfai; Ulo Langel
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

3.  Characterisation of the nociceptive phenotype of suppressible galanin overexpressing transgenic mice.

Authors:  Robert J P Pope; Fiona E Holmes; Niall C Kerr; David Wynick
Journal:  Mol Pain       Date:  2010-10-21       Impact factor: 3.395

4.  The neuropeptide galanin modulates behavioral and neurochemical signs of opiate withdrawal.

Authors:  Venetia Zachariou; Darlene H Brunzell; Jessica Hawes; Diann R Stedman; Tamas Bartfai; Robert A Steiner; David Wynick; Ulo Langel; Marina R Picciotto
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-09       Impact factor: 11.205

Review 5.  Modulation of pain, nociception, and analgesia by the brain reward center.

Authors:  Vasiliki Mitsi; Venetia Zachariou
Journal:  Neuroscience       Date:  2016-05-14       Impact factor: 3.590

6.  Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour.

Authors:  Fiona E Holmes; Nighat Arnott; Penny Vanderplank; Niall C H Kerr; Erin E Longbrake; Philip G Popovich; Toshio Imai; Christophe Combadière; Philip M Murphy; David Wynick
Journal:  J Neurochem       Date:  2008-04-12       Impact factor: 5.372

7.  RGS9-2--controlled adaptations in the striatum determine the onset of action and efficacy of antidepressants in neuropathic pain states.

Authors:  Vasiliki Mitsi; Dimitra Terzi; Immanuel Purushothaman; Lefteris Manouras; Sevasti Gaspari; Rachael L Neve; Maria Stratinaki; Jian Feng; Li Shen; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-24       Impact factor: 11.205

8.  Regulation of galanin and galanin receptor 2 expression by capsaicin in primary cultured dorsal root ganglion neurons.

Authors:  Zhen Liu; Zhenzhong Li
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-14       Impact factor: 2.416

9.  Endogenous galanin protects mouse hippocampal neurons against amyloid toxicity in vitro via activation of galanin receptor-2.

Authors:  Caroline R Elliott-Hunt; Fiona E Holmes; Dean M Hartley; Sylvia Perez; Elliott J Mufson; David Wynick
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.